Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • ASCO Offers Path to Address Cancer Drug Costs

    ASCO has released a new position statement that offers a path to address the affordability of cancer drugs. The statement includes recommendations focused on addressing affordability, preserving patient access to care, and fostering innovation.

    Read More
  • Senate Passes FDA Reauthorization Act

    The Senate has passed the Food and Drug Administration (FDA) Reauthorization Act, which governs FDA’s authority to collect user fees from the industry it regulates in order to fund core FDA programs.

    Read More
  • 2018 Medicare Physician Fee Schedule Proposed Rule Released

    CMS has released its proposed rule for 2018 Medicare physician reimbursement. CMS estimates that in CY 2018, reimbursement for the hematology/oncology specialty is set to remain the same, though the actual impact on individual physician practices will depend on the mix of services provided.

    Learn More

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15